FIELD: biology, medicine.
SUBSTANCE: invention relates to cartiotrofin (CT-1) expression enhancing in process of liver regeneration which consists with maximal hepatocyte proliferation. Also invention relates to application of CT-1 and composition based on the same as stimulator of liver regeneration, as well as hepatoprotective effect of CT-1 in various models of acute liver lesions.
EFFECT: application of CT-1 to improve liver functions at various pathologies thereof.
10 cl, 14 ex, 13 dwg
Title | Year | Author | Number |
---|---|---|---|
USE OF MODIFIED CYCLOSPORINES | 2007 |
|
RU2463071C2 |
THERAPEUTIC COMPOSITION FOR REDUCING RESISTANCE TO TYROSINE KINASE INHIBITORS | 2016 |
|
RU2735493C2 |
ANTIFIBROGENIC COMPOUNDS, METHODS AND USE THEREOF | 2014 |
|
RU2726416C2 |
APPLICATION OF MYXOMA VIRUS FOR THERAPEUTIC TREATMENT OF CANCER AND CHRONIC VIRUS INFECTION | 2004 |
|
RU2362584C2 |
THERAPEUTIC AGENT FOR TREATING NERVOUS SYSTEM DISEASE | 2018 |
|
RU2825666C2 |
TISSUE REGENERATION STIMULATING AGENT | 2013 |
|
RU2599289C2 |
COMPOSITION FOR DETECTION OF CANCER BLOOD DISEASES OR METASTASIS OF CANCER CONTAINING ACTIVE INGREDIENT MONOACETHYL DIGLYCERIDE COMPOUND | 2014 |
|
RU2632098C2 |
NOVEL TUMOUR BIOMARKER | 2010 |
|
RU2567005C2 |
METHOD AND COMPOSITION FOR DIAGNOSING AND TREATING CANCER | 1996 |
|
RU2174409C2 |
METHOD FOR TISSUE REGENERATION STIMULATION | 2007 |
|
RU2480213C2 |
Authors
Dates
2006-07-10—Published
2002-09-20—Filed